Huseyin Bilgin
Overview
Explore the profile of Huseyin Bilgin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ertas K, Gul O, Bozaci A, Bilgin H
Mol Genet Metab
. 2025 Mar;
144(4):109069.
PMID: 40048913
Aim: In mucopolysaccharidosis (MPS) disease, glycosaminoglycan (GAG) accumulates in the cardiovascular system and creates clinical conditions. Our aim in the study is to analyze the cardiac functions of MPS patients...
2.
Bilgin H, Yolbas I, Tekes S
J Clin Lipidol
. 2024 Nov;
18(6):e1067-e1073.
PMID: 39537506
Aim: The aim of this study was to examine the clinical, laboratory and demographic characteristics of patients diagnosed with cerebrotendinous xanthomatosis (CTX). Materials And Methods: This study included 11 patients...
3.
Ertas K, Gul O, Bozaci A, Bilgin H
J Pediatr Endocrinol Metab
. 2024 Jun;
37(8):701-708.
PMID: 38920264
Objectives: We aimed to cardiologically evaluate the consequences of glycosaminoglycan (GAG) accumulation in the large vessels of patients with mucopolysaccharidosis (MPS). Methods: The left ventricular wall thickness, left ventricular mass...
4.
Bilgin H, Basari T, Pazar N, Kucuker I, Can-Sarinoglu R
Infect Dis Clin Microbiol
. 2024 Apr;
5(3):231-238.
PMID: 38633557
Objective: This study aimed to compare 28-day mortality between patients have hospital-acquired influenza (HAI) and those have community-acquired influenza (CAI) during the 2017-2019 influenza seasons in a tertiary care center...
5.
Sili U, Ay P, Bilgin H, Topuzoglu A, Tukenmez-Tigen E, Erturk-Sengel B, et al.
Infect Dis Clin Microbiol
. 2024 Apr;
5(2):94-105.
PMID: 38633015
Objective: This study aimed to define the predictors of critical illness development within 28 days postadmission during the first wave of the COVID-19 pandemic. Materials And Methods: We conducted a...
6.
Bilgin H, Bozaci A
Mol Genet Metab Rep
. 2024 Mar;
39:101070.
PMID: 38516404
Aim: It was aimed to identify markers that would indicate which cases presenting with rhabdomyolysis are more likely to be associated with inherited metabolic diseases. Methods: We analyzed 327 children...
7.
Sili U, Tekin A, Bilgin H, Khan S, Domecq J, Vadgaonkar G, et al.
Int J Infect Dis
. 2023 Dec;
140:39-48.
PMID: 38128643
Objectives: COVID-19 escalated inappropriate antibiotic use. We determined the distribution of pathogens causing community-acquired co-infections, the rate, and factors associated with early empiric antibiotic (EEAB) treatment among hospitalized COVID-19 patients....
8.
Bilgin H, Ayaz E
Clin Imaging
. 2023 Nov;
105:110018.
PMID: 37984022
Purpose: Our aim is the early detection of mucopolysaccharidosis (MPS) by examining the radiographs taken for reasons other than a metabolic disease, such as infection, trauma, and short stature. Methods:...
9.
Aydin Z, Bilgin H, Cilasun C, Aydin I
Pediatr Nephrol
. 2023 May;
38(10):3283-3284.
PMID: 37140710
No abstract available.
10.
Aydin Z, Bilgin H, Cilasun C, Aydin I
Pediatr Nephrol
. 2023 May;
38(10):3281-3282.
PMID: 37140709
No abstract available.